Form 4: Sutro Biopharma CFO Edward Albini Reports Stock Transactions
SEC Form 4 Filing
CFO and Secretary of Sutro Biopharma, Edward Albini, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 5, 2025, Edward Albini, CFO and Secretary of Sutro Biopharma, reported transactions involving the company's common stock and restricted stock units (RSUs).
- Albini vested 8,750 shares of common stock from RSUs.
- 3,594 shares were withheld by the issuer to cover income tax obligations related to the RSU settlement at a price of $1.36.
- Following these transactions, Albini directly owns 132,081 shares of Sutro Biopharma common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| March 5, 2022 | Initial vesting date of RSUs, with 1/4th of the total award vesting annually thereafter. |
| March 5, 2025 | Date of reported transactions: RSU vesting and tax withholding. |
| March 7, 2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.